Submit RFI/RFP
Request ConsultationSafety & Compliance
Stay compliant and in control with proactive safety monitoring and expert risk management.
Explore More
Building Trust in Pharmaceutical Excellence
Regulatory Affairs & Market Entry
Submissions & Compliance
Explore More
Product Lifecycle
Lifecycle Management
Explore More
Let us guide you to the right solution
Our Story
Baupharma’s vision
When Baupharma was founded, the vision was to create more than a pharmaceutical service provider. The aim was to build a trusted global centre where scientific expertise, regulatory knowledge, and local market insight come together with one clear purpose: protecting patients worldwide.
As healthcare becomes increasingly interconnected and complex, our role is to turn that complexity into clarity, confidence, and meaningful action. We connect markets and support our partners in meeting the highest standards wherever they operate—building lasting partnerships, strengthening pharmaceutical systems, and creating a safer future for patients everywhere.
Global Reach
Expertise across the globe
With a wide geographical reach, Baupharma extends its expertise and services to clients and partners across the globe. Our global presence, supported by four strategic offices in different regions, enables us to deliver exceptional solutions that meet the unique requirements of each market.
Europe
MENA + South Africa
Sub-Saharan Africa
Russia + CIS
USA & CANADA
LATAM
Caribbean
APAC
How We Work
A clear, proven process for every project.
Step 1
Assessment
We evaluate your regulatory and pharmacovigilance requirements, objectives, and current compliance status.
Step 2
Strategy
We develop a tailored regulatory and safety strategy aligned with your products and target markets.
Step 3
Implementation
Our experts manage regulatory submissions, safety documentation, and pharmacovigilance activities.
Step 4
Engagement
We coordinate with regulatory authorities and stakeholders throughout the regulatory and safety lifecycle.
Step 5
Compliance
We support ongoing regulatory compliance, pharmacovigilance obligations, and post-market requirements.
Clients
Partners who trusted us
Quality Assurance
ISO 9001 Certification
- Documented international quality standards
- Full commitment to customer satisfaction
- Continuous improvement of processes and services
Latest Insights
Pharma Intelligence & Regulatory Updates
News / Featured
One Warning, Different Words : Does Risk Communication Work the Same Across the Arab Region
This webinar explores how risk communication can differ across the Arab region, even when addressing the same medicine safety concern.…
Blog
Why Pharmaceutical Registration Applications Get Delayed: Common Gaps in Regulatory Submissions
Pharmaceutical product registration is a critical step in bringing medicinal products to the market. It ensures that medicines meet the…
News / Important
EDE Launches “Speak Up… Stay Safe” Pharmacovigilance Campaign with Five UAE Health Authorities
The Emirates Drug Establishment (EDE) has launched its pharmacovigilance awareness campaign, “Speak Up… Stay Safe” in collaboration with five UAE…
News / Important
Baltic and Polish Medicines Agencies Discuss Regulatory Cooperation, Medicine Availability and Pharmaceutical Sector Developments
Baltic and Polish Medicines Agencies Meet to Discuss Shared Regulatory Priorities The 2026 Baltic and Polish Medicines Agencies Meeting brought…
News / Important
TGA Updates Guidance on Consent for Therapeutic Goods That Do Not Comply with Standards
The Australian Therapeutic Goods Administration (TGA) updated its industry guidance on 28 October 2026, revising the list of standards specified…
News / Important
AMA and EMA Issue Joint Guidance on Ebola Vaccine Development
The African Medicines Agency (AMA) and the European Medicines Agency (EMA) have published a joint position paper to support the…
Blog
CTD and eCTD: Building a High-Quality Regulatory Submission
In the pharmaceutical industry, a high-quality regulatory submission is essential for obtaining marketing authorization, maintaining product registrations, and ensuring compliance…
News / Important
FDA Issues Final Guidance on Prescription Drug Apps and Software
The U.S. Food and Drug Administration (FDA) issued final guidance on October 20, 2026, outlining how pharmaceutical companies should develop,…
Ready to simplify your journey?
Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.
Submit RFI/RFP